Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer Therapeutics

• Egile Nagusiak: Bao T. Le (Egilea), Prithi Raguraman (Egilea), Tamer R. Kosbar (Egilea), Susan Fletcher (Egilea), Steve D. Wilton (Egilea), Rakesh N. Veedu (Egilea)
• Formatua: Liburua
• Argitaratua: Elsevier, 2019-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Cancer is one of the leading causes of death worldwide, and conventional cancer therapies such as surgery, chemotherapy, and radiotherapy do not address the underlying molecular pathologies, leading to inadequate treatment and tumor recurrence. Angiogenic factors, such as EGF, PDGF, bFGF, TGF-β, TGF...